EyePoint Pharmaceuticals ... (EYPT)
EyePoint Pharmaceuticals Statistics
Share Statistics
EyePoint Pharmaceuticals has 68.81M shares outstanding. The number of shares has increased by 31.96% in one year.
| 68.81M |
| 31.96% |
| 0.7% |
| 99.99% |
| n/a |
| 351 |
| 0.04% |
Short Selling Information
The latest short interest is 7.21M, so 10.47% of the outstanding shares have been sold short.
| 7.21M |
| 10.47% |
| 12.56% |
| 11.69 |
Valuation Ratios
The PE ratio is -3.2 and the forward PE ratio is -2.82. EyePoint Pharmaceuticals's PEG ratio is -0.12.
| -3.2 |
| -2.82 |
| 9.69 |
| 0.9 |
| 1.25 |
| -3.22 |
| -0.12 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for EyePoint Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.06.
| 7.81 |
| 7.77 |
| 0.06 |
| -0.17 |
| -0.17 |
| -10418.14 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $262,260.61 |
| $-793,151.52 |
| 165 |
| 0.1 |
| 1.61 |
Taxes
| 90K |
| -0.07% |
Stock Price Statistics
The stock price has increased by -10.9% in the last 52 weeks. The beta is 1.64, so EyePoint Pharmaceuticals's price volatility has been higher than the market average.
| 1.64 |
| -10.9% |
| 6.1 |
| 7.77 |
| 72.87 |
| 835,368 |
Income Statement
In the last 12 months, EyePoint Pharmaceuticals had revenue of 43.27M and earned -130.87M in profits. Earnings per share was -2.32.
| 43.27M |
| 39.56M |
| -145.85M |
| -130.87M |
| -129.23M |
| -130.77M |
| -2.32 |
Balance Sheet
The company has 99.7M in cash and 21.86M in debt, giving a net cash position of 77.85M.
| 99.7M |
| 21.86M |
| 77.85M |
| -873.02M |
| 362.56M |
| 285.31M |
Cash Flow
In the last 12 months, operating cash flow was -126.23M and capital expenditures -4.05M, giving a free cash flow of -130.28M.
| -126.23M |
| -4.05M |
| -130.28M |
| -2.31 |
Margins
Gross margin is 91.42%, with operating and profit margins of -337.06% and -302.43%.
| 91.42% |
| -337.06% |
| -302.22% |
| -302.43% |
| -298.63% |
| -337.06% |
| -301.06% |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for EYPT is $26, which is 214.8% higher than the current price. The consensus rating is "Buy".
| $26 |
| 214.8% |
| Buy |
| 8 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Dec 9, 2020. It was a backward split with a ratio of 1:10.
| Dec 9, 2020 |
| backward |
| 1:10 |
Scores
| 0.68 |
| 2 |